Nitrosamines are classified as potential cancer-causing agents. The chemicals have been found in several prescription drugs in recent years, prompting recalls. Most recently, Pfizer issued a voluntary ...

Pharmaceutical company Merck said that it is working to reduce levels of a cancer-causing organic compound that was found in some of its popular type 2 diabetes drugs. The compound, called ...

The FDA has designated this a Class II recall. Over 7100 bottles of duloxetine have been recalled due to the presence of a nitrosamine impurity, N-nitroso-duloxetine, according to the Food and Drug ...

Nitrogen metabolism of gut bacteria can provide health benefits. Specifically, gut microbes metabolize dietary nitrates and nitrites and prevent the formation of cancer-causing compounds called ...

Our FDA Compliance & Enforcement Team highlights key takeaways from the Food and Drug Administration’s notice identifying scientific and regulatory considerations for nitrosamine drug ...

Since 2019, the FDA has reported dozens of drug recalls because of the presence of nitrosamine, a probable carcinogen that largely pulls blood pressure treatments off the market. Lawsuits against ...

Long-term use of a product containing N-nitroso-quinapril may be associated with an increased cancer risk based on data from closely related nitrosamine compounds. Aurobindo Pharma USA has voluntarily ...

To manage the potential data security and information accuracy risks associated with large language models, the European Medicines Agency’s guiding principles emphasize that medical staff using these ...

Pharmaceutical company Merck said that it is working to reduce levels of a cancer-causing organic compound that was found in some of its popular type 2 diabetes drugs.The compound, called nitrosamines ...